Chemotherapeutic resistance: surviving stressful situations
Luke A Gilbert1, Michael T Hemann
1Massachusetts Institute of Technology, Cambridge, MA, USA.
Abstract:
Chemotherapeutic regimens involve the systemic administration of genotoxic compounds that induce cancer cell death via well-established DNA damage response signaling networks. Less understood is how the treatment of other cell types within the tumor microenvironment affects the therapeutic response. Here we discuss recent work that shows that tumor-adjacent cells can respond to genotoxic stress by activating a paracrine secretory program. Although this secretory response serves to protect progenitor cells and promote tissue regeneration in conditions of cellular stress, it can also be coopted by tumor cells to survive frontline chemotherapy. Thus, local prosurvival signaling may present a fundamental barrier to tumor clearance by genotoxic agents, suggesting that effective treatments need to target both cancer cells and the tumor microenvironment.
Insights
Chemotherapy kills cancer cells, but nearby cells can protect tumors. Targeting both cancer cells and their microenvironment is crucial for effective cancer treatment.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment
Background:
- Chemotherapy uses genotoxic compounds to induce cancer cell death through DNA damage response pathways.
- The impact of non-cancerous cells in the tumor microenvironment on chemotherapy effectiveness is not fully understood.
Purpose of the Study:
- To investigate how tumor-adjacent cells respond to genotoxic stress.
- To explore the role of paracrine signaling from these cells in chemotherapy resistance.
Main Methods:
- Review of recent research on cellular responses to genotoxic stress.
- Analysis of paracrine secretory programs activated in tumor-adjacent cells.
Main Results:
- Tumor-adjacent cells activate a paracrine secretory program in response to genotoxic stress.
- This secretory response, while protective for progenitor cells, can be exploited by tumor cells for survival during chemotherapy.
- Local prosurvival signaling acts as a barrier to genotoxic agent efficacy.
Conclusions:
- Effective cancer chemotherapy requires targeting not only cancer cells but also the tumor microenvironment.
- Modulating prosurvival signaling in the tumor microenvironment may enhance treatment outcomes.
Related Concept Videos
Treatment Resistant Cancers
Other Stress Responses in Bacteria
Transduction
Psychological Responses to Stress
Introduction to Stress and Lifestyle
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

